Eur Rev Med Pharmacol Sci 2023; 27 (21): 10157-10170
DOI: 10.26355/eurrev_202311_34292

Y. An, H. Zhang, R. Wang, Y.-F. Shen, J.-L. Zhao, Y.-S. Zou, G.-Z. Wang

Affiliated Geriatric Hospital of Wuhan University of Science and Technology, Wuhan, P.R. China. ayin6666@163.com

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are common life-threatening, high-mortality lung diseases associated with acute and severe inflammation of the lungs. However, research on diagnostic markers and signaling pathways associated with ALI/ARDS is lacking, and no specific drug therapy is available for ALI/ARDS. Therefore, in this study, biomarkers and signaling pathways associated with ALI/ARDS were summarized to provide a reference for future clinical and research work. A review of Traditional Chinese Medicine for the treatment or prevention of ALI/ARDS is also presented to provide a reference for further development of Traditional Chinese Medicine. In summary, this review will help raise awareness of ALI/ARDS and provide insight into the future exploitation of Traditional Chinese Medicine.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Y. An, H. Zhang, R. Wang, Y.-F. Shen, J.-L. Zhao, Y.-S. Zou, G.-Z. Wang
Biomarkers, signaling pathways, and programmed cell death in acute lung injury and its treatment with Traditional Chinese Medicine: a narrative review

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 21
Pages: 10157-10170
DOI: 10.26355/eurrev_202311_34292